Marine-derived fungi have been reported to have great potential to produce structurally unique metabolites. Our investigation on secondary metabolites from marine-derived fungi resulted in the isolation of seven new polyketides (phomopsiketones D-G (1-4) and letendronols A-C (5-7)) as well as one known xylarinol (8) in the cultural broth of Letendraea sp. Their structures and absolute configurations were elucidated using a set of spectroscopic and chemical methods, including HRESIMS, NMR, single-crystal X-ray diffraction, ECD calculation, and a modified version of Mosher's method. Compound 2 showed weak inhibition against nitric oxide production in lipopolysaccaride-activated macrophages with an IC 50 value of 86 µM.
Introduction
Metabolites from marine-derived microorganisms have become important pharmacological resources [1, 2] . At least 2000 novel natural products have been identified in the past five years, nearly 50% of which were derived from marine-derived fungi [3] [4] [5] . In addition, the metabolic pathways of marine-derived fungi, which can be attributed to unique marine habitats, especially those that contain sea salts, may be significantly different from terrestrial ones [6] . Thus, marine-derived fungi have great potential to produce structurally unique metabolites and have attracted a considerable amount of attention.
In our ongoing research on bioactive secondary metabolites from marine-derived fungi, we isolated an endophytic fungus Letendraea sp. 5XNZ4-2 from one sea crab. We obtained two novel spiroketals (letenketals A and B) from this fungus [7] . In order to obtain more structurally novel compounds, the systematic discovery of secondary metabolites for this strain was carried out. Seven new polyketides (phomopsiketones D-G (1-4) and letendronols A-C (5-7), see Figure 1 ) as well as one known xylarinol (8) were isolated from a Potato DFextrose Broth (1/2 PDB) cultural broth. Herein, we report the isolation, structure elucidation, and bioactivities of these compounds. 
Results and Discussion
Compound 1 was obtained as a yellow amorphous powder. Its molecular formula was determined to be C13H20O4 (with 4 degrees of unsaturation) by HRESIMS (m/z 263.1256 for [M+Na] + ) and NMR data. IR absorption at 3426 and 1672 cm -1 indicated the presence of a hydroxyl and unsaturated ketones. 1 H-NMR (Table 1) Two fragments of -CH2(12)-CH3 (13) and -CH2(11)-CHO(10)-CH2(9)-, derived from 1 H-1 H COSY correlations of H3-13 (δH 0.95)/H2-12 (δH 1.43, 1.52) and H2-9 (δH 1.88, 2.36)/H-10 (δH 3.74)/H2-11 (δH 1.55, 1.61), were connected by the HMBC correlation from H2-12 to C-10 (δC 66.7) as one aliphatic chain. Then, this aliphatic chain of -CH2 (9)-CHO (10)-CH2 (11)-CH2 (12)-CH3 (13) was positioned at C-8 according to the HMBC correlations from H-9 to C-7 and H-10 to C-8. C-2 was connected with C-3 (δC 151.4) because of the HMBC correlations from H-2 to C-8, C-3, and C-4 (δC 65.3), and the oxygen bridge between C-2 and C-10 was determined by the HMBC correlation from H-2 to C-10. The methoxy was positioned at C-2 by the HMBC correlation from H3-15 (δH 3.50) to C-2 (δC 95.2). 
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Compound 1 was obtained as a yellow amorphous powder. Its molecular formula was determined to be C13H20O4 (with 4 degrees of unsaturation) by HRESIMS (m/z 263.1256 for [M+Na] + ) and NMR data. IR absorption at 3426 and 1672 cm -1 indicated the presence of a hydroxyl and unsaturated ketones. 1 H-NMR (Table 1 ) of 1 displayed one methoxy (δH 3.50, s) and one methyl (δH 0.95, t, J = 7.0 Hz). The 13 C NMR and DEPT displayed 13 carbon signals, including one α, βunsaturated ketone (δC 198.2), two olefinic carbons (δC 132.5, 151.4), one ketal carbon (δC 95.2), two oxygenated carbons (δC 65.3, 66.7), and one methoxy (δC 55.8). Calculation of unsaturation revealed that compound 1 contained a bicyclic skeleton. An α, β-unsaturated cyclohexanone moiety was derived from the 1 H-1 H Correlation Spectroscopy (COSY) correlations between H-4 (δH 4.59)/H2-5 (δH 2.06, 2.28)/H2-6 (δH 2.40, 2.70), coupled with the Heteronuclear Multiple Bond Correlation (HMBC) correlations from H2-5 to C-3 (δC 151.4) and C-7 (δC 198.2) and H2-6 to C-7 and C-8 (δC 132.5) ( Figure  2 ). Two fragments of -CH2(12)-CH3(13) and -CH2(11)-CHO(10)-CH2(9)-, derived from 1 H-1 H COSY correlations of H3-13 (δH 0.95)/H2-12 (δH 1.43, 1.52) and H2-9 (δH 1.88, 2.36)/H-10 (δH 3.74)/H2-11 (δH 1.55, 1.61), were connected by the HMBC correlation from H2-12 to C-10 (δC 66.7) as one aliphatic chain. Then, this aliphatic chain of -CH2 (9)-CHO (10)-CH2 (11)-CH2 (12)-CH3 (13) was positioned at C-8 according to the HMBC correlations from H-9 to C-7 and H-10 to C-8. C-2 was connected with C-3 (δC 151.4) because of the HMBC correlations from H-2 to C-8, C-3, and C-4 (δC 65.3), and the oxygen bridge between C-2 and C-10 was determined by the HMBC correlation from H-2 to C-10. The methoxy was positioned at C-2 by the HMBC correlation from H3-15 (δH 3.50) to C-2 (δC 95.2). Two fragments of -CH 2 (12)-CH 3 (13) and -CH 2 (11)-CHO(10)-CH 2 (9)-, derived from 1 , were connected by the HMBC correlation from H 2 -12 to C-10 (δ C 66.7) as one aliphatic chain. Then, this aliphatic chain of -CH 2 (9)-CHO (10)-CH 2 (11)-CH 2 (12)-CH 3 (13) was positioned at C-8 according to the HMBC correlations from H-9 to C-7 and H-10 to C-8. C-2 was connected with C-3 (δ C 151.4) because of the HMBC correlations from H-2 to C-8, C-3, and C-4 (δ C 65.3), and the oxygen bridge between C-2 and C-10 was determined by the HMBC correlation from H-2 to C-10. The methoxy was positioned at C-2 by the HMBC correlation from H 3 -15 (δ H 3.50) to C-2 (δ C 95.2).
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Compound 1 was determined to be a 5,6-deoxy and 2-methoxyated derivative of EI-1941-1 [8] and named phomopsiketone D.
In order to establish the relative configuration of 1, the Nuclear Overhauser Effect Spectroscopy (NOESY) was measured ( Figure S15 ). NOESY correlations between H-2/H-10 and H-6a/H-4 suggest that both of the cyclohexanone and dihydropyran (DHP) rings were in the twist chair conformation. The cross peaks between H-4/H-2/H-10 suggested that they adopted the same orientations. The absolute configuration of 1 was established by a comparison between the experimental ECD spectrum and the theoretically calculated values of two possible stereoisomers (2R, 4S, 10R)-1 and (2S, 4R, 10S)-1 [9,10]. The experimental ECD ( Figure 3 ) of 1 showed a positive Cotton effect at 325 nm and a negative Cotton effect at 230 nm, which matched well with the calculated value of (2R, 4S, 10R)-1, and contributed to determining the absolute configuration of 1 as (2R, 4S, 10R). Compound 1 was determined to be a 5,6-deoxy and 2-methoxyated derivative of EI-1941-1 [8] and named phomopsiketone D. In order to establish the relative configuration of 1, the Nuclear Overhauser Effect Spectroscopy (NOESY) was measured ( Figure S15 ). NOESY correlations between H-2/H-10 and H-6a/H-4 suggest that both of the cyclohexanone and dihydropyran (DHP) rings were in the twist chair conformation. The cross peaks between H-4/H-2/H-10 suggested that they adopted the same orientations. The absolute configuration of 1 was established by a comparison between the experimental ECD spectrum and the theoretically calculated values of two possible stereoisomers (2R, 4S, 10R)-1 and (2S, 4R, 10S)-1 [9, 10] . The experimental ECD ( Figure 3 ) of 1 showed a positive Cotton effect at 325 nm and a negative Cotton effect at 230 nm, which matched well with the calculated value of (2R, 4S, 10R)-1, and contributed to determining the absolute configuration of 1 as (2R, 4S, 10R). Compound 2 was obtained as a light brown oil. Its molecular formula was determined to be C18H30O5 (with 4 degrees of unsaturation) on the basis of its HRESIMS (m/z 349.1989 for [M+Na] + ) and NMR data. IR absorption at 3426 and 1678 cm -1 indicated the presence of a hydroxyl and unsaturated ketones. Its 13 C NMR and DEPT spectra ( Table 2 ) showed distinctive signals, including one α, β-unsaturated ketone (δC 197.9), two olefinic carbons (δC 131.5, 154.4), one ketal carbon (δC 95.6), and one oxygenated methine (δC 67.4), similar to those of 1, and indicated that compound 2 contained a similar bicyclic skeleton to that of 1. Additional signals, including three oxygenated methylenes (δC 68.4, 69.9, 71.5), two methylenes (δC 31.5, 19.3), and one methyl (δC 14.0), were observed, while the methoxy in 1 was absent in 2. These additional signals were organized as one Figure S1 ). The 2-butoxyethoxy group was connected to C-2 through an ether linkage according to the HMBC correlation from H2-15 to C-2 (δC 95.6). Thus, compound 2 was elucidated as shown in Figure 1 and named phomopsiketone E. Compound 2 was obtained as a light brown oil. Its molecular formula was determined to be C 18 H 30 O 5 (with 4 degrees of unsaturation) on the basis of its HRESIMS (m/z 349.1989 for [M+Na] + ) and NMR data. IR absorption at 3426 and 1678 cm −1 indicated the presence of a hydroxyl and unsaturated ketones. Its 13 C NMR and DEPT spectra ( Table 2 ) showed distinctive signals, including one α, β-unsaturated ketone (δ C 197.9), two olefinic carbons (δ C 131.5, 154.4), one ketal carbon (δ C 95.6), and one oxygenated methine (δ C 67.4), similar to those of 1, and indicated that compound 2 contained a similar bicyclic skeleton to that of 1. Additional signals, including three oxygenated methylenes (δ C 68.4, 69.9, 71.5), two methylenes (δ C 31.5, 19.3), and one methyl (δ C 14.0), were observed, while the methoxy in 1 was absent in 2. These additional signals were organized as one 2-butoxyethoxy group (CH 3 Figure S1 ). The 2-butoxyethoxy group was connected to C-2 through an ether linkage according to the HMBC correlation from H 2 -15 to C-2 (δ C 95.6). Thus, compound 2 was elucidated as shown in Figure 1 and named phomopsiketone E. The DHP and cyclohexanone rings were also in twist chair conformations according to the NOESY correlation between H-2 and H-10 as well as the H-6 axial and H-4. The ECD spectra ( Figure 3 ) of 1 and 2 showed similar curves (the cotton effect was positive at 325 nm (1) and 325 nm (2) , and negative at 230 nm (1) and 228 nm (2)), and determined the absolute configurations of (2R, 4S, 10R) for 2.
Compound 3 was obtained as a yellow oil. Its molecular formula was determined to be C 12 H 18 O 4 (with 4 degrees of unsaturation) on the basis of its HRESIMS (m/z 261.0895 for [M+Cl] -) and NMR data. Carbon NMR ( Table 2 ) showed 12 signals, including one α, β-unsaturated ketone (δ C 197.1), two olefinic carbons (δ C 136.0, 163.6), nine aliphatic carbons that were grouped into one methyl (δ C 14.4), five methylenes (δ C 20.0, 34.5, 35.6, 37.1, and 73.8 (oxygenated)), and three oxygenated methines (δ C 66.0, 74.4, 91.3), by an Heteronuclear singular Quantum Coherence (HSQC) spectrum. These signals were similar to those of phomopsiketone A [11] except that one methylene in 3 replaced one oxygenated methine in phomopsiketone A. Several NMR signals, including a multiplet for H-7 (δ H 4.67) ( Table 1) , and 1 H-1 H COSY correlations of H-7/H 2 -6/H 2 -5 ( Figure 2 ) indicated the presence of 6-CH 2 . Thus, 3 was determined to be 6-deoxy-phomopsiketone A and named phomopsiketone F.
The absolute configuration of 3 was determined by a modified version of Mosher's esterification method [12, 13] . Compound 3 was acylated with R-(−)-and S-(+)-α-methoxy-α (trifluoromethyl) phenylacetyl chloride (α-MTPA-Cl). The products were separated by preparative HPLC and purified as six compounds, which were determined to be the 7-S-MTPA ester (3a), 7-R-MTPA ester (3b), 10-S-MTPA ester (3c), 10-R-MTPA ester (3d), 7,10-di-S-MTPA ester (3e), and 7,10-di-R-MTPA ester (3f) by HRESIMS ( Figure 4 ) determined the configurations of C-7 and C-10 to be 7S and 10R, respectively. A NOESY correlation between H-7 (δ H 5.92) and H-10 (δ H 5.31) was observed in 3f and allowed us to deduce the configuration of C-9 as S ( Figures S5 and S92) . Thus, the absolute configuration of 3 was determined to be (7S, 9S, 10R). 5 .92) and H-10 (δH 5.31) was observed in 3f and allowed us to deduce the configuration of C-9 as S ( Figure S5 and S92). Thus, the absolute configuration of 3 was determined to be (7S, 9S, 10R). Compound 4 was also obtained as a yellow oil. Its molecular formula was established as C12H18O4, identical to that of 3, by HRESIMS (m/z 249.1101 for [M+Na] + ) and NMR data. The proton and carbon spectra were also similar to those of 3 (Tables 1 and 2 ) and a two-dimensional (2D) NMR analysis ( Figure S2 ) enabled us to deduce that it has the same planar structure as 3. Different ECD spectra of 3 and 4 ( Figure S8 ) were used to confirm that they were stereoisomers.
A NOESY correlation between H-7 and H-9 was not observed. Then, the modified version of Mosher's esterification method was applied to determine the absolute configuration of 4. Esterification of 4 with (R)-and (S)-MTPA-Cl yielded the 7,10-di-S-MTPA ester (4a) and the 7,10-di-R-MTPA ester (4b), respectively. The similar 1 H NMR chemical shift differences (Δ4e-4f, Figures S6 and 3 ) around the C-7 and C-10 stereocenters as 3 indicated the 7S and 10R configurations for 4. Since 4 was the stereoisomer of 3, the configuration of C-9 in 4 was deduced to be R, contrary to that in 3. Thus, the absolute configuration of 4 was determined to be (7S, 9R, 10R) and it was named phomopsiketone G.
Compound 5 was crystallized as colorless needles in acetone. Its HRESIMS showed an ion peak [M+Na] + at m/z 251.1258, corresponding to the molecular formula C12H20O4 and possessing two hydrogen atoms more than 3 and 4. A comparison of 13 C NMR data between 3 and 5 revealed that the ketone carbonyl (δC 197.1, C-4 in 3) was replaced by one oxygenated methine ( Table 2 ). 1 H-1 H COSY correlations between H-4 (δH 4.06)/H-5 (δH 1.54, 2.02)/H-6 (δH 1.56, 2.07)/ H-7(δH 4.43) ( Figure  S3 ) confirmed that the ketone carbonyl was hydrogenated. A similar C5 side chain (CH3-13/CH2-12/CH2-11/CH-10/CH-9) to that in 3 was derived from 1 H-1 H COSY correlations ( Figure  S3 ). Key HMBC correlations from H-2 (δH 4.02) to C-10 (δC 80.4) and H-9 (δH 3.99) to C-3 (δC 137.1) ( Figure S3 ) indicated the presence of a dihydropyran fragment that was different from the dihydrofuran in 3. Thus, 5 was determined to be a new polyketide and named letendronol A.
In order to establish the relative configuration, 5 was crystallized and, by use of X-ray analysis ( Figure 5 ), H-4 and H-9 were assigned to the same orientation, and H-7 and H-10 were assigned to the opposite orientation of H-4 and H-9.
The tri-(S/R) MTPA esters (5a/5b) were obtained by the modified version of Mosher's method together with HPLC purification. A 1 H NMR data comparison of 5a and 5b (Δ5a-5b, Figure S7 ) determined the absolute configurations of (4S, 7S, 9R) in 5. Finally, the configuration of 5 was unambiguously confirmed to be (4S, 7S, 9R, and 10S) by X-ray analysis combined with the modified version of Mosher's method. Compound 4 was also obtained as a yellow oil. Its molecular formula was established as C 12 H 18 O 4 , identical to that of 3, by HRESIMS (m/z 249.1101 for [M+Na] + ) and NMR data. The proton and carbon spectra were also similar to those of 3 (Tables 1 and 2 ) and a two-dimensional (2D) NMR analysis ( Figure S2 ) enabled us to deduce that it has the same planar structure as 3. Different ECD spectra of 3 and 4 ( Figure S8 ) were used to confirm that they were stereoisomers.
A NOESY correlation between H-7 and H-9 was not observed. Then, the modified version of Mosher's esterification method was applied to determine the absolute configuration of 4. Esterification of 4 with (R)-and (S)-MTPA-Cl yielded the 7,10-di-S-MTPA ester (4a) and the 7,10-di-R-MTPA ester (4b), respectively. The similar 1 H NMR chemical shift differences (∆δ 4e -4f , Figure S6 and Figure 3 ) around the C-7 and C-10 stereocenters as 3 indicated the 7S and 10R configurations for 4. Since 4 was the stereoisomer of 3, the configuration of C-9 in 4 was deduced to be R, contrary to that in 3. Thus, the absolute configuration of 4 was determined to be (7S, 9R, 10R) and it was named phomopsiketone G.
Compound 5 was crystallized as colorless needles in acetone. Its HRESIMS showed an ion peak [M+Na] + at m/z 251.1258, corresponding to the molecular formula C 12 H 20 O 4 and possessing two hydrogen atoms more than 3 and 4. A comparison of 13 C NMR data between 3 and 5 revealed that the ketone carbonyl (δ C 197.1, C-4 in 3) was replaced by one oxygenated methine ( Figure S3 ) confirmed that the ketone carbonyl was hydrogenated. A similar C 5 side chain (CH 3 -13/CH 2 -12/CH 2 -11/CH-10/CH-9) to that in 3 was derived from 1 H-1 H COSY correlations ( Figure S3 ). Key HMBC correlations from H-2 (δ H 4.02) to C-10 (δ C 80.4) and H-9 (δ H 3.99) to C-3 (δ C 137.1) ( Figure S3 ) indicated the presence of a dihydropyran fragment that was different from the dihydrofuran in 3. Thus, 5 was determined to be a new polyketide and named letendronol A.
The tri-(S/R) MTPA esters (5a/5b) were obtained by the modified version of Mosher's method together with HPLC purification. A 1 H NMR data comparison of 5a and 5b (∆δ 5a -5b , Figure S7 ) determined the absolute configurations of (4S, 7S, 9R) in 5. Finally, the configuration of 5 was unambiguously confirmed to be (4S, 7S, 9R, and 10S) by X-ray analysis combined with the modified version of Mosher's method.
Compound 6 was contained as a colorless amorphous powder. It has the same molecular formula (C 12 H 20 O 4 ) as 5 according to its HRESIMS (m/z 251.1260 for [M+Na] + ) and 13 C NMR data. One dimensional (1D) NMR data (Tables 1 and 2 Compound 6 was contained as a colorless amorphous powder. It has the same molecular formula (C12H20O4) as 5 according to its HRESIMS (m/z 251.1260 for [M+Na] + ) and 13 C NMR data. One dimensional (1D) NMR data (Tables 1 and 2) combined with a 2D NMR analysis ( Figure S3 ) revealed 6 to have the same planar structure as 5. Compound 6 was deduced to be a stereoisomer of 5 because of their different retention times when eluted by the same HPLC program and was named letendronol B. Figure 5 . The X-ray crystal structure of 5 (the thermal ellipsoid was 30%). Compounds 6 and 5 contained different a configuration at C-4, which was assigned by the modified version of Mosher's method. Treatment of 6 with (R)-or (S)-MTPA-Cl yielded the tri-(S/R) MTPA esters (6a/6b). The result of the application of the modified version of Mosher's method (Δ6a-6b, Figure S7 ) revealed 7S and 9R configurations, identical to 5, and a 4R configuration different from 5, in 6. H-9 and H-10 were also assigned to different orientations according to the broad singlet peaks for H-9 in 6a (δH 5.11, br s) and 6b (δH 4.78, br s) ( Figure S110 ), similar to those in 5a (δH 5.19, br s) and 5b (δH 4.76, br s) ( Figures S98) . Then, the absolute configuration of 6 was determined to be (4R, 7S, 9R, and 10S).
Compound 7 was obtained as a white amorphous powder. The molecular formula of 7 was determined to be C12H16O3 with 5 degrees of unsaturation by its HRESIMS (m/z 231.0995 for [M+Na] + ) and NMR data. The 1 H NMR (Table 1) [14] ([α] 25 D -28.5) was used to determine that the absolute configurations at C-9 and C-10 were R and S, respectively. The 9R and 10S configurations of 7 were also confirmed by a comparison between the experimental ECD spectrum and the theoretically calculated values of (9R, 10S)-7. The experimental ECD ( Figure 6 ) of 7 showed a positive Cotton effect at 195 and a negative Cotton effect at 205 nm, which matched well with the calculated value of (9R, 10S)-7.
The known compound 8 was determined to be xylarinol by comparison of its NMR data with the reported literature [15] . Figure S7 ) revealed 7S and 9R configurations, identical to 5, and a 4R configuration different from 5, in 6. H-9 and H-10 were also assigned to different orientations according to the broad singlet peaks for H-9 in 6a (δ H 5.11, br s) and 6b (δ H 4.78, br s) ( Figure S110 ), similar to those in 5a (δ H 5.19, br s) and 5b (δ H 4.76, br s) ( Figure S98 ). Then, the absolute configuration of 6 was determined to be (4R, 7S, 9R, and 10S).
Compound 7 was obtained as a white amorphous powder. The molecular formula of 7 was determined to be C 12 H 16 O 3 with 5 degrees of unsaturation by its HRESIMS (m/z 231.0995 for [M+Na] + ) and NMR data. The 1 H NMR (Table 1) 20 D +9) with that of (3R,4S)-6,8-Dihydroxy-1,1-dimethyl-3,4,5-trimethylisochroman [14] ([α] 25 D -28.5) was used to determine that the absolute configurations at C-9 and C-10 were R and S, respectively. The 9R and 10S configurations of 7 were also confirmed by a comparison between the experimental ECD spectrum and the theoretically calculated values of (9R, 10S)-7. The experimental ECD ( Figure 6 Compounds 1, 2, 3, and 5 were evaluated for their inhibitory activities against Lipopolysaccharide (LPS)-activated NO production in RAW264.7 [16] , and all tested compounds showed no cytotoxicity to macrophage cells at the concentration of 100 μM and 50 μM by the MTT method. Compound 2 showed weak anti-inflammatory activity with an IC50 value of 86 μΜ. Hydrocortisone was used as a positive control with the IC50 value of 22.4 μM. The other compounds showed no anti-inflammatory activity with IC50 values of >100 μM. All compounds were assayed for their cytotoxicity against the prostate cancer PC3 cell line by the MTT method [17] . Compounds 1-3, 5, 6, and 8 were also assayed for antibacterial activity against Staphylococcus aureus, Staphylococcus epidermidis, Escherichia coli, Miconia albicans and Pseudomonas aeruginosa using the Kirby−Bauer Diffusion method. Regrettably, none of these compounds showed any activities in the cytotoxicity and antibacterial tests.
Materials and Methods

General Experimental Procedures
Optical rotations were measured on Rudolph research analytical AUTOPOL I. The ultraviolet spectra were obtained from a Shimadzu UV-1800 spectrophotometer using MeOH as the solvent. Electronic circular dichroism (ECD) spectra were obtained on a JASCO J-1500 circular dichroism. The infrared (IR) spectra were acquired from a Bruker Vector 22. NMR spectra were recorded on a Bruker AVIII 500 MHz and JEOL 600 Hz, using TMS as the internal standard. HRESIMS spectra were obtained from an Agilent 6224 TOF LC/MS. Analytical HPLC was performed on an Agilent 1260 system using a C18 (Cosmosil, 5 μm, 4.6 × 250 mm) column. The column chromatography was carried out using Silica gel (200-300 mesh, Qing Dao Hai Yang Chemical Group Co., Qing Dao, China).
Fungal Material and Fermentation
The Letendraea sp. was isolated from the gut of a crab found on Zhairuoshan Island (N20.2920, E122.5), Zhoushan, Zhejiang Province, China, in August 2015. The fungus was determined to be Letendraea sp. by 26s rDNA sequence analysis (GenBank accession no. MK743951), and produced a sporulating, white-colored culture when growing on potato-dextrose agar (PDA). The strain was deposited (NO. 5XNZ4-2) at the Institute of Marine Biology of Zhejiang University. The strain was static cultured at 28 °C for 30 days in 500 mL Erlenmeyer flasks (100 × 200 mL, a total of 20 L) each containing 200 mL of 1/2 PDB liquid media (100 g of potato extract, 17 g of artificial sea salt, and 10 g of dextrose in 1 L pure water). The known compound 8 was determined to be xylarinol by comparison of its NMR data with the reported literature [15] .
Compounds 1, 2, 3, and 5 were evaluated for their inhibitory activities against Lipopolysaccharide (LPS)-activated NO production in RAW264.7 [16] , and all tested compounds showed no cytotoxicity to macrophage cells at the concentration of 100 µM and 50 µM by the MTT method. Compound 2 showed weak anti-inflammatory activity with an IC 50 value of 86 µM. Hydrocortisone was used as a positive control with the IC 50 value of 22.4 µM. The other compounds showed no anti-inflammatory activity with IC 50 values of >100 µM. All compounds were assayed for their cytotoxicity against the prostate cancer PC3 cell line by the MTT method [17] . Compounds 1-3, 5, 6 , and 8 were also assayed for antibacterial activity against Staphylococcus aureus, Staphylococcus epidermidis, Escherichia coli, Miconia albicans and Pseudomonas aeruginosa using the Kirby−Bauer Diffusion method. Regrettably, none of these compounds showed any activities in the cytotoxicity and antibacterial tests.
Materials and Methods
General Experimental Procedures
Optical rotations were measured on Rudolph research analytical AUTOPOL I. The ultraviolet spectra were obtained from a Shimadzu UV-1800 spectrophotometer using MeOH as the solvent. Electronic circular dichroism (ECD) spectra were obtained on a JASCO J-1500 circular dichroism. The infrared (IR) spectra were acquired from a Bruker Vector 22. NMR spectra were recorded on a Bruker AVIII 500 MHz and JEOL 600 Hz, using TMS as the internal standard. HRESIMS spectra were obtained from an Agilent 6224 TOF LC/MS. Analytical HPLC was performed on an Agilent 1260 system using a C18 (Cosmosil, 5 µm, 4.6 × 250 mm) column. The column chromatography was carried out using Silica gel (200-300 mesh, Qing Dao Hai Yang Chemical Group Co., Qing Dao, China).
Fungal Material and Fermentation
The Letendraea sp. was isolated from the gut of a crab found on Zhairuoshan Island (N20.2920, E122.5), Zhoushan, Zhejiang Province, China, in August 2015. The fungus was determined to be Letendraea sp. by 26s rDNA sequence analysis (GenBank accession no. MK743951), and produced a sporulating, white-colored culture when growing on potato-dextrose agar (PDA). The strain was deposited (NO. 5XNZ4-2) at the Institute of Marine Biology of Zhejiang University. The strain was static cultured at 28 • C for 30 days in 500 mL Erlenmeyer flasks (100 × 200 mL, a total of 20 L) each containing 200 mL of 1/2 PDB liquid media (100 g of potato extract, 17 g of artificial sea salt, and 10 g of dextrose in 1 L pure water).
Extraction and Isolation
The culture broth (20 L) was filtered and extracted with equivoluminal EtOAc three times to obtain 2.79 g of metabolite extract, which was fractionated by column chromatography (CC) over silica gel (200−300 mesh, 60 g) and eluted in a gradient of petroleum ether (P)-EtOAc(E) (20:1-1:1) to yield 10 fractions (Frs. 1-10) based on TLC analysis. Fr. 7 was further separated via preparative HPLC with a C18 (Agilent, 10 µm, 21.2 × 250 mm) column at 210 nm, eluting with MeOH/H 2 O (40/60, v/v) at 8 mL/min to obtain four sub-fractions (Fr. 7.1-7.4). Fr. 7.1 (110 mg) was purified with semi-preparative HPLC (Agilent C18 column, 10 µm, 10 × 250 mm, MeCN/H 2 O 10:90, 4 mL/min, 210 nm) to yield 3 (73 mg). Fr. 10 was purified by CC over silica gel (200−300 mesh, 30 g) using a gradient of CH 2 Cl 2 -MeOH (50:1-1:1) as a mobile phase to provide five fractions (Fr. [11] [12] [13] [14] [15] 
ECD Calculation of Compound 1
Monte Carlo conformational searches were carried out by means of the Spartan's 10 software using Merck Molecular Force Field (MMFF). The conformers with a Boltzmann population of over 5% were chosen for ECD calculations, and then the conformers were initially optimized at the B3LYP/6-31+g (d, p) level in MeOH using the CPCM polarizable conductor calculation model. The theoretical calculation of ECD was conducted in MeOH using time-dependent density functional theory (TD-DFT) at the B3LYP/6-311+g (d, p) level for all conformers of compound 1. Rotatory strengths for a total of 50 excited states were calculated. ECD spectra were generated using the program SpecDis 1.6 (University of Würzburg, Würzburg, Germany) and GraphPad Prism 5 (University of California San Diego, USA) from dipole-length rotational strengths by applying Gaussian band shapes with sigma = 0.3 eV [18] . 
Preparation of MTPA Esters of Compound 3
Preparation of MTPA Esters of Compounds 4-6
Compounds 4 (1 mg), 5 (4 mg), and 6 (1.5 mg) in 1 mL of anhydrous pyridine were separated into two equal portions. (R)-or (S)-MTPA chloride (50 µL each) was added into each portion, respectively. Each reaction mixture was stirred at ambient temperature for 4 h and the reaction was terminated by adding 1 mL of methanol. HPLC was also used for the isolation of (S)-MTPA ester -4 (4a, 0.7 mg) and (R)-MTPA ester -4 (4b, 0.7 mg). The (S)-MTPA and (R)-MTPA esters of 5 (5a, 5.0 mg; 5b, 5.7 mg) and 6 (6a, 2.30 mg; 6b, 1.92 mg) were also prepared in a similar manner. S-MTPA Ester of 6 (6a): White amorphous solid. 1 
X-Ray Crystallographic Analysis
Compound 5 was obtained as colorless crystals from acetone-ethyl acetate (1:4) using the vapor-exchanged method [11, 19, 20] . X-ray single-crystal diffraction data for 5 were collected at 293 K on a Rigaku Oxford Diffraction instrument using Cu Kα (λ = 1.54184) radiation. The structures were solved by direct methods using Olex2 software [21] , and the non-hydrogen atoms were refined isotropically with SHELXL-2014 [22] using a full-matrix least squares procedure based on F 2 . The hydrogen atoms were positioned according to the geometric calculation. Crystallographic data for the structures of 5 were deposited at the Cambridge Crystallographic Data Centre database (CCDC Number: 1890797).
Crystal 
NO Inhibition Assay
Mouse monocyte-macrophages RAW 264.7 (ATCC TIB-71) were purchased from the Chinese Academy of Science. DMEM medium, penicillin, streptomycin, and fetal bovine serum were purchased from Invitrogen (N.Y., USA). Lipopolysaccharide (LPS), DMSO, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT), and hydrocortisone were obtained from Sigma Co. RAW 264.7 cells were maintained in DMEM medium supplemented with penicillin, streptomycin (both 100 U/mL), and 10% heat-inactivated fetal bovine serum at 37 • C in a humidified incubator with 5% CO 2 and 95% air. RAW264.7 cells were passaged until they attained confluence. The cell concentration was adjusted to 5 × 10 5 cells/mL with 10% FBS DMEM medium, and 100 µL was seeded in each well of a 96-well plate that was maintained at 37 • C overnight. The supernatant was discarded, and the cells except for the blank control groups were treated with 100 µL of LPS DMEM (the concentration of LPS was 2 µg/mL or 5 µg/mL). After 2 h of incubation, blank and LPS model groups were treated with 100 µL of DMEM medium and the others were treated with DMEM medium containing various concentrations of test compounds for 24 h, respectively [16] .
As a parameter of NO release, the nitrite concentration was measured in the supernatant of RAW 264.7 cells by the Griess reaction [16] . The inhibition rate was calculated and plotted versus test concentrations to afford the IC 50 .
Cytotoxic Assay
The cytotoxicity of all of the compounds was measured by the MTT assay against the prostate cancer PC3 cell line. Tumor cell lines were seeded in 96-well plates (4000 per well in 100 µL). After 24 h of incubation, cells were treated with gradient concentrations (100 µM, 50 µM, 25 µM, 12.5 µM,
